| PACKAGING TYPE: | 10x15 Alu-alu (10 Strips In 1 Box) |
| COMPOSITION: | Voglibose (0.2mg) |
| FORMULATION: | Tablet |
| Description: | VONISH-0.2 Tablet contains Voglibose 0.2mg, an oral antidiabetic medication used for the management of type 2 diabetes mellitus. Voglibose belongs to the alpha-glucosidase inhibitor class, which works by slowing down the absorption of carbohydrates in the intestines. This helps in controlling postprandial (after-meal) blood sugar spikes, improving overall glycemic control. |
| Side Effects: | Common side effects: Flatulence (gas) Mild abdominal discomfort Diarrhea Nausea Rare side effects: Severe abdominal pain Allergic reactions |
| How to Use: | Take the tablet as prescribed by your doctor Usually taken before meals, 2–3 times daily depending on diet and prescription Swallow the tablet with water Monitor blood sugar levels regularly |
| Precaution: | Use cautiously in patients with intestinal obstruction or chronic intestinal disorders Inform your doctor about all medications and health conditions Not recommended during pregnancy or breastfeeding unless advised Monitor blood sugar regularly for optimal glycemic control |
| Product Benefits: | Controls postprandial blood glucose levels Slows intestinal carbohydrate absorption Helps manage type 2 diabetes mellitus Can be used alone or in combination with other oral antidiabetic agents Supports overall glycemic stability Low risk of hypoglyc |
Frequently Asked Questions
It is used to manage type 2 diabetes by controlling post-meal blood sugar spikes.
Voglibose inhibits alpha-glucosidase enzymes in the intestine, slowing carbohydrate absorption and reducing postprandial blood glucose.
Yes, it can be combined with other oral antidiabetic agents under medical supervision for better glycemic control.




















